---
title: "300683.SZ (300683.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300683.SZ/news.md"
symbol: "300683.SZ"
name: "300683.SZ"
parent: "https://longbridge.com/en/quote/300683.SZ.md"
datetime: "2026-05-20T15:37:41.055Z"
locales:
  - [en](https://longbridge.com/en/quote/300683.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300683.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300683.SZ/news.md)
---

# 300683.SZ (300683.SZ) — Related News

### [HITECK has obtained the drug registration certificate for injectable isavuconazole](https://longbridge.com/en/news/286733629.md)
*2026-05-18T07:52:03.000Z*
> HITECK recently obtained the Drug Registration Certificate for injectable isavuconazole approved by the National Medical

### [HITECK: The key task for 2026 is to promote the construction of new production capacity for Apatinib](https://longbridge.com/en/news/284701608.md)
*2026-04-30T05:46:12.000Z*
> HITECK recently stated at the performance briefing that Apatinib has now entered the medical insurance system, and by 20

### [HITECK: Net loss of 23.0463 million yuan in the first quarter of 2026](https://longbridge.com/en/news/283843453.md)
*2026-04-23T13:29:32.000Z*
> HITECK announced that its revenue for the first quarter of 2026 was 159 million yuan, a year-on-year increase of 1.52%; 

### [EVEREST MED signs acquisition agreement with Haisen Biotech to expand its commercial footprint in the Asia-Pacific region](https://longbridge.com/en/news/281942755.md)
*2026-04-07T23:35:03.000Z*
> EVEREST MED has signed an acquisition agreement with Haisen Biotech to acquire all the shares of Haisen Singapore, with 

### [](https://longbridge.com/en/news/281815620.md)
*2026-04-07T01:41:35.000Z*
> Innovative drug concept stocks rapidly plummeted, with NEPTUNUS hitting the daily limit, RemeGen falling more than 10%, 

### [The medical services sector opened weaker](https://longbridge.com/en/news/281592181.md)
*2026-04-03T01:38:06.000Z*
> The medical services sector opened weaker, with ChemPartner, R&G Pharma, and HITECK falling over 5%, followed by INKON L

### [Shanghai Composite Index Volatile Up, Innovative Drugs and Auto Stocks Rally Mid-day, Commercial Aerospace Active, Hang Seng Tech Index Surges and Falls Back, Tech Stocks Diverge](https://longbridge.com/en/news/281111117.md)
*2026-03-31T08:37:30.000Z*
> The automotive vehicle sector showed strength, with the bus segment leading the gains. Yutong Bus and SG Automotive Grou

### [The innovative drug concept is repeatedly active, TJPC has three consecutive limit-ups](https://longbridge.com/en/news/281102415.md)
*2026-03-31T01:36:36.000Z*
> The innovative drug concept is repeatedly active, TJPC has three consecutive limit-ups, and Asymchem, JOINN, Pharmaron, 

### [CRO and innovative drug sector surged at the beginning of the trading session, Menovo hit the daily limit](https://longbridge.com/en/news/280239359.md)
*2026-03-24T01:49:12.000Z*
> CRO and innovative drug sectors surged at the beginning of the trading session, with Menovo hitting the limit up, Kingch